Healthcare Professionals

Get evaluated

Find a HeartMate II LVAD Center


HeartMate II confidence

HeartMate II is proven and trusted worldwide for Bridge to TransplantationX CLOSEBridge to Transplantation –Temporary support forpeople with heart failure who are waiting for a heart transplant. Bridge to Transplantation involves the use of a left ventricular assist device (LVAD). and Destination TherapyX CLOSEDestination Therapy –Permanent support for advanced-stage heart failure for patients who do not qualify for a heart transplant. Destination Therapy refers to the implantation of a ventricular assist device (VAD) for long-term use, rather than as a Bridge to Transplantation. in the treatment of advanced heart failureX CLOSEAdvanced Heart Failure –The heart of a person with advanced heart failure has a hard time pumping blood. This results in the body getting less oxygen. It makes a person feel tired or weak, even when doing simple things, such as walking or eating. Advanced heart failure (AHF) is defined as Classes IIIb and IV in the New York Heart Association (NYHA) Functional Classification and StagesC and D in the AHA/ACC Stages of Heart Failure..


  • HeartMate II has been in clinical use for over 10 years, providing advanced heart failure patients with a viable treatment option
  • HeartMate II helped 4 out of 5 people become free or almost free of advanced heart failure symptoms just 6 months after surgery—and those improvements lasted for at least 2 years*
  • HeartMate II helped advanced heart failure patients walk significantly farther than they could before being implanted
  • HeartMate II is the most widely used and studied LVAD in the world
  • HeartMate II’s safety and efficacy has been demonstrated in over 300 medical papers

“I thought the LVAD was just going to be a Bridge to Transplantation, but as time went on, I started feeling so much better. I feel so good that I cannot see taking that step, so I’m not actively seeking a heart right now.”

Kristi HeartMate II recipient and patient advocate


  • HeartMate II has been implanted in more than 20,000 advanced heart failure patients
  • HeartMate II is used in over 350 hospitals in 41 countries
  • HeartMate II is the only LVAD approved for both Bridge to Transplantation and Destination Therapy in the US
  • HeartMate II is manufactured by Thoratec Corporation, a company committed to innovating therapies for advanced heart failure patients for over 35 years

LVAD surgery, like any major surgery, comes with some risks, including: bleeding, infection, stroke, device malfunction, and death. Talk to your doctor to understand the risks.

Getting an LVAD comes with some risks. For potential complications and adverse events, click here.

For indications for use, contraindications, warnings, and adverse events view our HeartMate II safety information. Individual experiences, symptoms, situations, and circumstances may vary. Please consult your physician or qualified healthcare provider regarding your condition and appropriate medical treatment.

*Based on published data from multicenter experience and separate studies, which may involve different patient populations and other variables.Please consult the HeartMate II Patient Handbook.
Data as of October 2013.

Register to stay informed and request information:

Quick Poll


Your response to this quick poll helps us create better experiences for our visitors. Please tell us about yourself. (Check all that apply)

I am an advanced heart failure patient seeking new treatment. I am a caregiver looking for treatment alternatives. I am familiar with HeartMate II and LVADs and want to learn more. My doctor has talked to me about HeartMate II/LVAD therapy, and I want to learn more.